Which medication is a vitamin K antagonist that may increase ocular bleeding risk?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Study for the NBEO Part II TMOD Exam. Prepare with flashcards and multiple choice questions, each with hints and explanations. Get ready for your exam!

Multiple Choice

Which medication is a vitamin K antagonist that may increase ocular bleeding risk?

Explanation:
Warfarin is a vitamin K antagonist that reduces the production of vitamin K–dependent clotting factors II, VII, IX, and X (as well as proteins C and S) by inhibiting vitamin K–reductase. This decreases the blood’s clotting ability and increases bleeding risk, including in ocular tissues. The other medications work through different mechanisms: antiplatelet agents like clopidogrel (Plavix) and aspirin, as well as NSAIDs, impair platelet function or COX activity but do not inhibit vitamin K–dependent factor synthesis. Therefore, the medication that may increase ocular bleeding risk specifically through vitamin K antagonism is warfarin.

Warfarin is a vitamin K antagonist that reduces the production of vitamin K–dependent clotting factors II, VII, IX, and X (as well as proteins C and S) by inhibiting vitamin K–reductase. This decreases the blood’s clotting ability and increases bleeding risk, including in ocular tissues. The other medications work through different mechanisms: antiplatelet agents like clopidogrel (Plavix) and aspirin, as well as NSAIDs, impair platelet function or COX activity but do not inhibit vitamin K–dependent factor synthesis. Therefore, the medication that may increase ocular bleeding risk specifically through vitamin K antagonism is warfarin.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy